Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the company has obtained a worldwide co-exclusive license for the biomarker PI3K (phosphoinositide 3-kinase) from QIAGEN to develop real-time and endpoint PCR diagnostic assays. Johns Hopkins University owns the patent for the PI3K biomarker and has previously granted an exclusive license to QIAGEN’s wholly owned subsidiary […]
CINCINNATI – Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its new molecular amplification assay, illumigene(TM) C.difficile. Clostridium difficile is a bacterium that can cause diarrhea and, in severe cases, a life-threatening inflammation of the colon. The illumigene molecular amplification assay […]
Easy-to-use molecular test offers faster results to help healthcare facilities control spread of methicillin-resistant Staphylococcus aureus (MRSA) Basel – Roche Molecular Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food & Drug Administration (FDA) cleared its new LightCycler MRSA Advanced Test for the detection of methicillin-resistant Staphylococcus aureus (MRSA) for clinical […]
Dortmund, Germany – Protagen AG, Dortmund, and the Neuried, Germany, based diagnostics company Mikrogen GmbH, announced today the closing of a collaboration agreement for the identification of typical autoantibody signatures in infectious diseases. Also classical infectious disease diagnostics can benefit from UNIarray®, the proprietary technology platform of Protagen for the determination of indication specific autoantibody […]
Preclinical Animal Data Demonstrates Promising Stem Cell Therapeutic Strategy for HIV/AIDS – Extends ZFP Therapeutic Application RICHMOND, Calif. – Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the publication of data demonstrating the preclinical efficacy of a human stem cell therapy for human immunodeficiency virus (HIV) based on its proprietary zinc finger DNA-binding protein nuclease (ZFN) technology. […]
Signature Diagnostics Will Commercialize First Microarray-Based Products for Detecting and Predicting Progression of Colorectal Cancer Santa Clara, Calif. & Postdam, Germany – Affymetrix, Inc. (NASDAQ:AFFX) and Signature Diagnostics AG (Signature Dx) today announced that they have signed a Powered by Affymetrix(TM) (PbA) agreement. Under the agreement, Signature Dx obtains a worldwide license to use Affymetrix(R) […]
RUNCORN, Cheshire – Thermo Fisher Scientific Inc., the world leader in serving science, today announced its latest STP 420ES tissue processor for use in high-volume pathology laboratories. The updated instrument features more robust hardware and ease-of-use, enabling the high-throughput processing of large volumes of tissue to meet the demands of today’s laboratories. The Thermo Scientific […]
Exiqon A/S (NASDAQ OMX Copenhagen: “EXQ”), today announced that it has granted a non-exclusive license to BD (Becton, Dickinson and Company) to use Exiqon’s proprietary locked nucleic acids (LNA™) technology in defined products for infectious disease diagnostics. Exiqon will receive upfront and milestone payments, and royalty on global sales of the products covered by this […]
Development of New Tests for Applications in Prevention and Personalized Healthcare – Extended HLA testing portfolio includes products to assess tolerance for Lumiracoxib and for the early detection of inflammatory diseases Germantown, MD and Hilden, Germany — QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced that it has entered into an agreement with the […]
MUKILTEO, Wash. — — CombiMatrix Corporation (Nasdaq:CBMX) announced today that its laboratory services subsidiary, CombiMatrix Diagnostics, has received the final licensure documentation and approvals from Medicare in order to begin billing for its suite of array-based diagnostics tests. “We have publicly disclosed that our Company continues to make significant progress on the reimbursement front,” stated […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
